Page last updated: 2024-10-18

glycine and Glycine Encephalopathy

glycine has been researched along with Glycine Encephalopathy in 75 studies

Research Excerpts

ExcerptRelevanceReference
"Glycine encephalopathy (GE), also known as non-ketotic hyperglycinemia, is a life-threatening metabolic disease caused by inherited deficiency of the glycine cleavage system (GCS)."8.87Two novel laboratory tests facilitating diagnosis of glycine encephalopathy (nonketotic hyperglycinemia). ( Kure, S, 2011)
"Glycine encephalopathy (GCE) is a rare autosomal recessive disorder caused by defects in the glycine cleavage complex."7.81Novel compound heterozygous LIAS mutations cause glycine encephalopathy. ( Matsumoto, N; Miyake, N; Nakashima, M; Ogata, K; Saitsu, H; Shiina, M; Shimada, S; Shimojima, K; Tanaka, R; Tsurusaki, Y; Yamamoto, T, 2015)
" The patient was found to have glycine encephalopathy resulting from a previously defined mutation in the GLDC gene."7.80Diagnosis of glycine encephalopathy in a pediatric patient by detection of a GLDC mutation during initial next generation DNA sequencing. ( Adıyaman, G; Biberoğlu, G; Çiftci, B; Ezgu, F; Gökmenoğlu, H; Hasanoğlu, A; Kasapkara, Ç; Küçükçongar, A; Topçu, B; Tümer, L, 2014)
"Classic neonatal-onset glycine encephalopathy (GE) is devastating and life threatening."7.73Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation. ( Flusser, H; Galil, A; Korman, SH; Kure, S; Matsubara, Y; Sato, K, 2005)
"Glycine encephalopathy, or nonketotic hyperglycinaemia (NKH; Mckusick 238300) is a severe autosomal recessive disease due to a defect in the glycine cleavage system (GCS), which is a complex of four subunits: P-, T-, H- and L-proteins."7.73Genetic heterogeneity of the GLDC gene in 28 unrelated patients with glycine encephalopathy. ( Bonnet, V; Cheillan, D; Conter, C; Froissart, R; Maire, I; Rolland, MO, 2006)
"Glycine encephalopathy (GE) (non-ketotic hyperglycinemia) is an autosomal recessive neurometabolic disease caused by defective activity of the glycine cleavage system."7.73A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem. ( Ben-Neriah, Z; Boneh, A; Kanno, J; Korman, SH; Kure, S; Lerer, I; Matsubara, Y; Sato, K, 2005)
"A defect in the P-protein component of the glycine cleavage system has been the most frequent abnormality found in patients with glycine encephalopathy (NKH)."7.72Molecular genetic and potential biochemical characteristics of patients with T-protein deficiency as a cause of glycine encephalopathy (NKH). ( Applegarth, DA; Coulter-Mackie, MB; Lee, G; Levy, HL; Toone, JR, 2003)
"An asphyxiated neonate with pyridoxine-dependent seizures and associated transient nonketotic hyperglycinemia is reported."7.70Transient nonketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures. ( Goto, K; Inutsuka, M; Izumi, T; Maeda, T, 2000)
"Glycine is a major neurotransmitter that activates inhibitory glycine receptors and is a co-agonist for excitatory glutamatergic N-methyl-D-aspartate (NMDA) receptors."5.43Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine. ( Armbruster, A; Baris, HN; Ekhilevitch, N; Eulenburg, V; Hannappel, E; Hauf, K; Hershkovitz, D; Hershkovitz, T; Ilivitzki, A; Kurolap, A; Mahajnah, M; Mandel, H; Mory, A; Nijem, Y; Paperna, T; Sella, E; Tal, G, 2016)
"Glycine encephalopathy, also known as nonketotic hyperglycinemia (NKH), is an inherited neurometabolic disorder with variable clinical course and severity, ranging from infantile epileptic encephalopathy to psychiatric disorders."4.12Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia. ( Cortès-Saladelafont, E; Garbade, SF; García-Cazorla, Á; García-Jiménez, MC; Guder, P; Hoffmann, GF; Honzík, T; Horvath, G; Ibáñez, S; Jeltsch, K; Juliá-Palacios, NA; Kulhánek, J; Kuseyri Hübschmann, O; Kuster, A; Olivella, M; Opladen, T; Pearson, TS; Santer, R; Zafeiriou, DI, 2022)
"GLYT1 encephalopathy is a form of glycine encephalopathy caused by disturbance of glycine transport."4.02GLYT1 encephalopathy: Further delineation of disease phenotype and discussion of pathophysiological mechanisms. ( Casellas-Vidal, D; Diego-Álvarez, D; Espuña-Capote, N; García-González, MDM; Mademont-Soler, I; Maroto, A; Obón, M; Perapoch, J; Queralt, X; Ruiz, MD; Trujillo, A, 2021)
"Delayed emergence from anesthesia was previously reported in a case study of a child with Glycine Encephalopathy."4.02Elevated preoptic brain activity in zebrafish glial glycine transporter mutants is linked to lethargy-like behaviors and delayed emergence from anesthesia. ( Bindernagel, R; Buglo, E; Dallman, JE; Engert, F; Kelz, MB; Meng, QC; Randlett, O; Sloan, SA; Stark, MJ; Sumathipala, SH; Syed, S; Venincasa, MJ; Yan, Q; Züchner, S, 2021)
"Nonketotic hyperglycinemia (NKH) or glycine encephalopathy is an autosomal recessive disorder of glycine metabolism resulting in an excessive accumulation of glycine in all body tissues, including the central nervous system."3.91Nonketotic Hyperglycinemia: Two Case Reports and Review. ( Al Futaisi, A; Al Murshidi, F; Al Thihli, K; Poothrikovil, RP, 2019)
"Glycine encephalopathy (GE), or nonketotic hyperglycinemia (NKH), is a rare recessive genetic disease caused by defective glycine cleavage and characterized by increased accumulation of glycine in all tissues."3.88Glycine decarboxylase deficiency-induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level. ( Drapeau, P; Greene, NDE; Lepage, N; Leung, KY; Liao, M; Pena, IA; Riché, R; Samarut, É; Sarafoglou, K; Schimmenti, LA, 2018)
"Glycine cleavage system (GCS) catalyzes the degradation of glycine and disruption of its components encoded by GLDC, AMT and GCSH are the only known causes of glycine encephalopathy, also known as non-ketotic hyperglycinemia (NKH)."3.83Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans. ( Alfadhel, M; Alfares, A; Ali, QA; Alkuraya, F; Alrifai, MT; Arold, ST; Douglas, GV; Juusola, J; Mutairi, FA; Nashabat, M; Qahtani, HA; Shaalan, HA; Wierenga, K, 2016)
" The patient was found to have glycine encephalopathy resulting from a previously defined mutation in the GLDC gene."3.80Diagnosis of glycine encephalopathy in a pediatric patient by detection of a GLDC mutation during initial next generation DNA sequencing. ( Adıyaman, G; Biberoğlu, G; Çiftci, B; Ezgu, F; Gökmenoğlu, H; Hasanoğlu, A; Kasapkara, Ç; Küçükçongar, A; Topçu, B; Tümer, L, 2014)
"Classic neonatal-onset glycine encephalopathy (GE) is devastating and life threatening."3.73Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation. ( Flusser, H; Galil, A; Korman, SH; Kure, S; Matsubara, Y; Sato, K, 2005)
"Glycine encephalopathy (GE) (non-ketotic hyperglycinemia) is an autosomal recessive neurometabolic disease caused by defective activity of the glycine cleavage system."3.73A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem. ( Ben-Neriah, Z; Boneh, A; Kanno, J; Korman, SH; Kure, S; Lerer, I; Matsubara, Y; Sato, K, 2005)
"A defect in the P-protein component of the glycine cleavage system has been the most frequent abnormality found in patients with glycine encephalopathy (NKH)."3.72Molecular genetic and potential biochemical characteristics of patients with T-protein deficiency as a cause of glycine encephalopathy (NKH). ( Applegarth, DA; Coulter-Mackie, MB; Lee, G; Levy, HL; Toone, JR, 2003)
" NKH is classically associated with neonatal apnea, lethargy, hypotonia, and seizures, followed by severe psychomotor retardation in those who survive."3.72Natural history of nonketotic hyperglycinemia in 65 patients. ( Applegarth, D; Hamosh, A; Hoover-Fong, JE; Shah, S; Toone, J; Van Hove, JL, 2004)
"An asphyxiated neonate with pyridoxine-dependent seizures and associated transient nonketotic hyperglycinemia is reported."3.70Transient nonketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures. ( Goto, K; Inutsuka, M; Izumi, T; Maeda, T, 2000)
"Glycine has multiple neurotransmitter functions in the central nervous system (CNS)."2.43Lessons from the knocked-out glycine transporters. ( Armsen, W; Betz, H; Eulenburg, V; Gomeza, J, 2006)
"Nonketotic hyperglycinemia is an autosomal recessive inborn error of glycine metabolism, characterized by deficient activity of the glycine cleavage enzyme system."1.62Genotypic and phenotypic features in Turkish patients with classic nonketotic hyperglycinemia. ( Bayrak, H; Ceylaner, S; Kasapkara, ÇS; Kılıç, M; Küçükcongar, A; Olgaç, A; Yıldız, Y; Yüksel, D; Zenciroğlu, A, 2021)
"High glycine (GLY) levels have been suggested to induce neurotoxic effects in the central nervous system of patients with nonketotic hyperglycinemia (NKH)."1.48Glycine Administration Alters MAPK Signaling Pathways and Causes Neuronal Damage in Rat Brain: Putative Mechanisms Involved in the Neurological Dysfunction in Nonketotic Hyperglycinemia. ( Fernandez Cardoso, GM; Gasparotto, J; Gelain, DP; Grings, M; Leipnitz, G; Moreira, JCF; Moura, AP; Parmeggiani, B; Seminotti, B; Wajner, M, 2018)
"This is the case for nonketotic hyperglycinemia (NKH), a Mendelian disorder causing seizures in neonates and early-infants, primarily due to mutations in the GLDC gene."1.46Nonketotic hyperglycinemia: Functional assessment of missense variants in GLDC to understand phenotypes of the disease. ( Abia, D; Arribas-Carreira, L; Bravo-Alonso, I; Couce, ML; Domingo, R; García-Cazorla, A; Morais, A; Navarrete, R; Pérez, B; Pérez-Cerdá, C; Perona, A; Ramos, MA; Rodríguez-Pombo, P; Swanson, MA; Ugarte, M; Van Hove, JLK, 2017)
"Glycine is a major neurotransmitter that activates inhibitory glycine receptors and is a co-agonist for excitatory glutamatergic N-methyl-D-aspartate (NMDA) receptors."1.43Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine. ( Armbruster, A; Baris, HN; Ekhilevitch, N; Eulenburg, V; Hannappel, E; Hauf, K; Hershkovitz, D; Hershkovitz, T; Ilivitzki, A; Kurolap, A; Mahajnah, M; Mandel, H; Mory, A; Nijem, Y; Paperna, T; Sella, E; Tal, G, 2016)
"Nonketotic hyperglycinemia is a neurometabolic disorder characterized by intellectual disability, seizures, and spasticity."1.42Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. ( Applegarth, DA; Bjoraker, KJ; Coughlin, CR; Creadon-Swindell, G; Hennermann, JB; Mahieu, V; Matthijs, G; Scharer, GH; Spector, EB; Swanson, MA; Szerlong, HJ; Tong, S; Toone, JR; Van Hove, JL; Williams, K, 2015)
"We report 3 cases of nonketotic hyperglycinemia, 2 typical neonatal and 1 atypical, diagnosed in Pediatric Hospital of Coimbra, Portugal, and investigated at Laboratory of Biochemical Genetics in 2004 to 2010 (incidence 1:47 455; prevalence 1:782 951)."1.39Nonketotic hyperglycinemia: a cause of encephalopathy in children. ( Diogo, L; Garcia, P; Grazina, M; Henriques, R; Robalo, C; Simões, M; Veríssimo, C, 2013)
"Hyperglycinemia was induced in healthy vervet monkeys when treated with a single oral dose of 50 mg/kg valproate."1.38Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate. ( Bergh, JJ; Kotze, HF; Mienie, LJ; Terre'Blanche, G; Viljoen, J, 2012)
"The diagnosis of nonketotic hyperglycinemia is traditionally based on the finding of a raised cerebrospinal fluid-to-plasma-glycine ratio."1.36Intracerebral blood and MRS in neonatal nonketotic hyperglycinemia. ( Cheong, JL; Manley, BJ; Sokol, J, 2010)
"Patients affected by nonketotic hyperglycinemia (NKH) usually present severe neurological symptoms and suffer from acute episodes of intractable seizures with leukoencephalopathy."1.35Glycine provokes lipid oxidative damage and reduces the antioxidant defenses in brain cortex of young rats. ( Amaral, AU; Beskow, AP; Dutra Filho, CS; Fernandes, CG; Leipnitz, G; Seminotti, B; Solano, AF; Wajner, M, 2009)
"Nonketotic hyperglycinemia was confirmed enzymatically."1.34Late-onset nonketotic hyperglycinemia with leukodystrophy and an unusual clinical course. ( Carpenter, K; Chiong, MA; Procopis, P; Wilcken, B, 2007)
"His glycine index was 0."1.34Neonatal nonketotic hyperglycinemia. ( Bhamkar, RP; Colaco, P, 2007)
"The glycine index is a stable, individually specific parameter in patients with NKH."1.33Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. ( De Becker, M; Declercq, P; Hennermann, JB; Jaeken, J; Kishnani, PS; Mahieu, V; Mertens, S; Van Hove, JL; Vande Kerckhove, K, 2005)
"Neonatal-type nonketotic hyperglycinemia treatment remains unsatisfactory, even if started early."1.32Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan. ( Chien, YH; Chou, SP; Hsu, CC; Huang, A; Hwu, WL; Lee, WT; Lu, FL, 2004)
"Three of four nonketotic hyperglycinemia patients homozygous for a novel GLDC mutation (A802V) were treated by assisted respiration and/or sodium benzoate with or without ketamine and had transient neonatal or absent symptoms and normal developmental outcome, despite persisting biochemical evidence of nonketotic hyperglycinemia."1.32Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation. ( Boneh, A; Ergaz, Z; Gomori, JM; Gutman, A; Ichinohe, A; Kojima, K; Korman, SH; Kure, S; Sato, K, 2004)
"Nonketotic hyperglycinemia is a life-threatening disorder in neonates characterized by a deficiency of the glycine cleavage system."1.31Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia. ( Chabrol, B; Confort-Gouny, S; Cozzone, PJ; Nicoli, F; Viola, A; Viout, P, 2002)
"Inherited deficiency of the GCS causes nonketotic hyperglycinemia (NKH), an inborn error of glycine metabolism."1.31Structure and expression of the glycine cleavage system in rat central nervous system. ( Aoki, Y; Hisanaga, K; Kojima, K; Kondo, H; Kure, S; Matsubara, Y; Owada, Y; Sakata, Y; Sato, K; Satoh, J; Shinka, T; Suzuki, Y, 2001)
"This leukoencephalopathy has an autosomal-recessive mode of inheritance."1.30Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. ( Gabreëls, FJ; Jaeken, J; Kure, S; van der Knaap, MS; van Raaij-Selten, B; Verhoeven, NM; Wevers, RA, 1999)
"The diagnosis of nonketotic hyperglycinemia is considered to depend upon the presence of increased cerebrospinal fluid glycine and an increased cerebrospinal fluid to plasma glycine ratio."1.30Atypical nonketotic hyperglycinemia with normal cerebrospinal fluid to plasma glycine ratio. ( Applegarth, DA; Jackson, AH; Kure, S; Levy, HL; Toone, JR, 1999)

Research

Studies (75)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (4.00)18.2507
2000's29 (38.67)29.6817
2010's30 (40.00)24.3611
2020's13 (17.33)2.80

Authors

AuthorsStudies
Swanson, MA6
Miller, K1
Young, SP1
Tong, S2
Ghaloul-Gonzalez, L1
Neira-Fresneda, J1
Schlichting, L1
Peck, C1
Gabel, L1
Friederich, MW2
Van Hove, JLK7
Kuseyri Hübschmann, O1
Juliá-Palacios, NA1
Olivella, M1
Guder, P1
Zafeiriou, DI1
Horvath, G1
Kulhánek, J1
Pearson, TS1
Kuster, A1
Cortès-Saladelafont, E1
Ibáñez, S1
García-Jiménez, MC1
Honzík, T1
Santer, R2
Jeltsch, K1
Garbade, SF1
Hoffmann, GF1
Opladen, T1
García-Cazorla, Á2
Arribas-Carreira, L2
Dallabona, C1
Farris, J2
Østergaard, E1
Tsiakas, K1
Hempel, M1
Aquaviva-Bourdain, C1
Koutsoukos, S1
Stence, NV3
Magistrati, M1
Spector, EB2
Kronquist, K3
Christensen, M1
Karstensen, HG1
Feichtinger, RG1
Achleitner, MT1
Lawrence Merritt Ii, J1
Pérez, B2
Ugarte, M3
Grünewald, S1
Riela, AR1
Julve, N1
Arnoux, JB1
Haldar, K2
Donnini, C1
Lund, AM1
Mayr, JA1
Rodriguez-Pombo, P3
Shelkowitz, E2
Saneto, RP2
Al-Hertani, W2
Lubout, CMA2
Brown, MS2
Long, P2
Walleigh, D2
Nelson, JA2
Perez, FE2
Shaw, DWW2
Michl, EJ2
Poothrikovil, RP1
Al Thihli, K1
Al Futaisi, A1
Al Murshidi, F1
Nasrallah, F2
Ben Chehida, A1
Kraoua, I1
Hadj-Taieb, S2
Sanhaji, H2
Tebib, N2
Feki, M2
Kaabachi, N2
Leung, KY3
De Castro, SCP1
Santos, C1
Savery, D2
Prunty, H2
Gold-Diaz, D1
Bennett, S1
Heales, S2
Copp, AJ2
Greene, NDE2
Ichikawa, K1
Inami, Y1
Kaneko, K1
Chehida, AB1
Jelassi, A1
Ben Massoued, S1
Charfi, M1
Zidi, W1
Amri, F1
Helel, KB1
Mejaoual, H1
Seboui, H1
Mahdhaoui, N1
Gargouri, A1
Monastiri, K1
Turki, I1
Cheour, M1
Mademont-Soler, I1
Casellas-Vidal, D1
Trujillo, A1
Espuña-Capote, N1
Maroto, A1
García-González, MDM1
Ruiz, MD1
Diego-Álvarez, D1
Queralt, X1
Perapoch, J1
Obón, M1
Alam, MS1
Rajashekara, AM1
Venincasa, MJ1
Randlett, O1
Sumathipala, SH1
Bindernagel, R1
Stark, MJ1
Yan, Q1
Sloan, SA1
Buglo, E1
Meng, QC1
Engert, F1
Züchner, S1
Kelz, MB1
Syed, S1
Dallman, JE1
Bayrak, H1
Yıldız, Y1
Olgaç, A1
Kasapkara, ÇS1
Küçükcongar, A2
Zenciroğlu, A1
Yüksel, D1
Ceylaner, S2
Kılıç, M1
Majethia, P1
Somashekar, PH1
Hebbar, M1
Kadavigere, R1
Praveen, BK1
Girisha, KM1
Shukla, A1
Scalais, E1
Osterheld, E1
Weitzel, C1
De Meirleir, L1
Mataigne, F1
Martens, G1
Shaikh, TH1
Coughlin, CR3
Yu, HC1
Swanson, M1
Scharer, G1
Helbling, D1
Wendt-Andrae, J1
Garcia, SM1
Spector, E2
Creadon-Swindell, G3
Walter, M1
Christensen, E1
Sass, JO1
Lin, Y1
Zheng, Z1
Sun, W1
Fu, Q1
Sato, K5
Riché, R1
Liao, M1
Pena, IA1
Lepage, N1
Sarafoglou, K1
Schimmenti, LA1
Drapeau, P1
Samarut, É1
Magwebu, ZE1
Mazinu, M1
Abdul-Rasool, S1
Chauke, CG1
Knaepper-Martin, S1
Boix, H1
Ezgu, F1
Çiftci, B1
Topçu, B1
Adıyaman, G1
Gökmenoğlu, H1
Kasapkara, Ç1
Biberoğlu, G1
Tümer, L1
Hasanoğlu, A1
Yilmaz, BS1
Kor, D1
Mert, GG1
Incecik, F1
Kartal, E1
Mungan, NO1
Pai, YJ1
Hutchin, T2
Brosnan, ME1
Brosnan, JT1
Greene, ND1
Tsurusaki, Y1
Tanaka, R1
Shimada, S1
Shimojima, K1
Shiina, M1
Nakashima, M1
Saitsu, H1
Miyake, N1
Ogata, K1
Yamamoto, T1
Matsumoto, N1
Scharer, GH2
Szerlong, HJ1
Bjoraker, KJ1
Mahieu, V3
Matthijs, G2
Hennermann, JB2
Applegarth, DA6
Toone, JR6
Williams, K1
Van Hove, JL4
Acquaviva, C1
Väisänen, ML1
Brás-Goldberg, AM1
Rahikkala, E1
Moilanen, JS1
Bravo-Alonso, I2
Pérez-Cerdá, C2
Vianey-Saban, C1
Contreras-Roura, J1
Camayd-Viera, I1
Padrón-Díaz, AD1
Martínez-Rey, L1
Alfadhel, M1
Nashabat, M1
Qahtani, HA1
Alfares, A1
Mutairi, FA1
Shaalan, HA1
Douglas, GV1
Wierenga, K1
Juusola, J1
Alrifai, MT1
Arold, ST1
Alkuraya, F1
Ali, QA1
Kurolap, A1
Armbruster, A1
Hershkovitz, T1
Hauf, K1
Mory, A1
Paperna, T1
Hannappel, E1
Tal, G1
Nijem, Y1
Sella, E1
Mahajnah, M1
Ilivitzki, A1
Hershkovitz, D1
Ekhilevitch, N1
Mandel, H2
Eulenburg, V2
Baris, HN1
Moura, AP1
Parmeggiani, B1
Gasparotto, J1
Grings, M1
Fernandez Cardoso, GM1
Seminotti, B3
Moreira, JCF1
Gelain, DP1
Wajner, M3
Leipnitz, G3
Navarrete, R1
Perona, A1
Abia, D1
Couce, ML1
Morais, A1
Domingo, R1
Ramos, MA1
Solano, AF1
Amaral, AU2
Fernandes, CG2
Beskow, AP1
Dutra Filho, CS1
Manley, BJ1
Sokol, J1
Cheong, JL1
Meyer, S1
Shamdeen, MG1
Furtwängler, R1
Gottschling, S1
Gortner, L1
Suzuki, Y3
Kure, S10
Oota, M1
Hino, H1
Fukuda, M1
August, DA1
Nguyen, HG1
Aburahma, S1
Khassawneh, M1
Griebel, M1
Sharp, G1
Gibson, J1
Brunel-Guitton, C1
Casey, B1
Coulter-Mackie, M1
Vallance, H1
Hewes, D1
Stockler-Ipsiroglu, S1
Mercimek-Mahmutoglu, S1
Knebel, LA1
da Rosa, MS1
Eichler, P1
Viljoen, J1
Bergh, JJ1
Mienie, LJ1
Kotze, HF1
Terre'Blanche, G1
Veríssimo, C1
Garcia, P1
Simões, M1
Robalo, C1
Henriques, R1
Diogo, L1
Grazina, M1
Madu, AE1
Oliver, L1
Viola, A1
Chabrol, B1
Nicoli, F1
Confort-Gouny, S1
Viout, P1
Cozzone, PJ1
Korman, SH4
Gutman, A2
Paupe, A1
Bidat, L1
Sonigo, P1
Lenclen, R1
Molho, M1
Ville, Y1
Levy, HL2
Coulter-Mackie, MB3
Lee, G1
Chien, YH1
Hsu, CC1
Huang, A1
Chou, SP1
Lu, FL1
Lee, WT1
Hwu, WL1
Boneh, A2
Ichinohe, A1
Kojima, K3
Ergaz, Z1
Gomori, JM1
Hoover-Fong, JE1
Shah, S1
Applegarth, D1
Toone, J1
Hamosh, A1
Atay, E1
Bozaykut, A1
Sezer, G1
Flusser, H1
Matsubara, Y5
Galil, A1
Kanno, J1
Lerer, I1
Ben-Neriah, Z1
Okamura-Ikeda, K1
Hosaka, H1
Yoshimura, M1
Yamashita, E1
Toma, S1
Nakagawa, A1
Fujiwara, K1
Motokawa, Y1
Taniguchi, H1
Kaźmierczuk-Skubis, ME1
Zatorska-Karpuś, M1
Pac-Kozuchowska, E1
Bojko-Jaworska, J1
Furmaga-Jabłońska, W1
Vande Kerckhove, K1
Declercq, P1
Mertens, S1
De Becker, M1
Kishnani, PS1
Jaeken, J2
Conter, C1
Rolland, MO2
Cheillan, D1
Bonnet, V1
Maire, I1
Froissart, R1
Gomeza, J1
Armsen, W1
Betz, H1
Liu, CM1
Fan, SZ1
Tan, ES1
Wiley, V1
Carpenter, K2
Wilcken, B2
Chiong, MA1
Procopis, P1
Bhamkar, RP1
Colaco, P1
Lang, TF1
Parr, JR1
Matthews, EE1
Gray, RG1
Bonham, JR1
Kay, JD1
Leisti, J1
Sakata, Y3
Tada, K1
Narisawa, K2
Jackson, AH1
van der Knaap, MS1
Wevers, RA1
Gabreëls, FJ1
Verhoeven, NM1
van Raaij-Selten, B1
Maeda, T1
Inutsuka, M1
Goto, K1
Izumi, T1
James, ER2
Gabis, L1
Parton, P1
Roche, P1
Lenn, N1
Tudorica, A1
Huang, W1
Kudo, T1
Kanno, K1
Aoki, Y2
Shinka, T2
Owada, Y1
Hisanaga, K1
Satoh, J1
Kondo, H1
Huisman, TA1
Thiel, T1
Steinmann, B1
Zeilinger, G1
Martin, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effects of Glycine Transport Inhibition on Brain Glycine Concentration[NCT00538070]68 participants (Actual)Interventional2007-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for glycine and Glycine Encephalopathy

ArticleYear
[Amplitude-integrated electroencephalography in non-ketotic hyperglycinaemia].
    Revista de neurologia, 2014, Jan-01, Volume: 58, Issue:1

    Topics: Carnitine; Consanguinity; Dextromethorphan; Drug Therapy, Combination; Early Diagnosis; Electroencep

2014
Two novel laboratory tests facilitating diagnosis of glycine encephalopathy (nonketotic hyperglycinemia).
    Brain & development, 2011, Volume: 33, Issue:9

    Topics: Breath Tests; Carbon Radioisotopes; Glycine; Glycine Dehydrogenase (Decarboxylating); Humans; Hyperg

2011
Non-ketotic hyperglycinaemia: case report and review of medical literature.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2013, Volume: 26, Issue:5

    Topics: Adult; Diagnosis, Differential; Fatal Outcome; Female; Gestational Age; Glycine; Hiccup; Humans; Hyp

2013
Lessons from the knocked-out glycine transporters.
    Handbook of experimental pharmacology, 2006, Issue:175

    Topics: Animals; Brain; Disease Models, Animal; Gene Expression Regulation; Glycine; Glycine Plasma Membrane

2006

Other Studies

71 other studies available for glycine and Glycine Encephalopathy

ArticleYear
Cerebrospinal fluid amino acids glycine, serine, and threonine in nonketotic hyperglycinemia.
    Journal of inherited metabolic disease, 2022, Volume: 45, Issue:4

    Topics: Amino Acids; Cross-Sectional Studies; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant, Newborn;

2022
Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia.
    Annals of neurology, 2022, Volume: 92, Issue:2

    Topics: Glycine; Humans; Hyperglycinemia, Nonketotic; Mutation; Phenotype

2022
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined nonketotic hyperglycinemia and lipoate deficiency.
    Human molecular genetics, 2023, 03-06, Volume: 32, Issue:6

    Topics: Exons; Glycine; Humans; Hyperglycinemia, Nonketotic; Mutation; Proteins

2023
Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.
    Orphanet journal of rare diseases, 2022, 12-05, Volume: 17, Issue:1

    Topics: Benzoates; Brain; Diet, Ketogenic; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant

2022
Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.
    Orphanet journal of rare diseases, 2022, 12-05, Volume: 17, Issue:1

    Topics: Benzoates; Brain; Diet, Ketogenic; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant

2022
Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.
    Orphanet journal of rare diseases, 2022, 12-05, Volume: 17, Issue:1

    Topics: Benzoates; Brain; Diet, Ketogenic; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant

2022
Ketogenic diet as a glycine lowering therapy in nonketotic hyperglycinemia and impact on brain glycine levels.
    Orphanet journal of rare diseases, 2022, 12-05, Volume: 17, Issue:1

    Topics: Benzoates; Brain; Diet, Ketogenic; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant

2022
Nonketotic Hyperglycinemia: Two Case Reports and Review.
    The Neurodiagnostic journal, 2019, Volume: 59, Issue:3

    Topics: Agenesis of Corpus Callosum; Apnea; Brain; Brain Diseases; Electroencephalography; Fatal Outcome; Fe

2019
Non-ketotic hyperglycinaemia: a frequent, but poorly diagnosed and managed genetic disorder in Tunisia.
    Archives of disease in childhood, 2021, Volume: 106, Issue:3

    Topics: Apnea; Chromatography, Ion Exchange; Coma; Consanguinity; Glycine; Humans; Hyperglycinemia, Nonketot

2021
Regulation of glycine metabolism by the glycine cleavage system and conjugation pathway in mouse models of non-ketotic hyperglycinemia.
    Journal of inherited metabolic disease, 2020, Volume: 43, Issue:6

    Topics: Alleles; Animals; Brain; Glycine; Glycine Dehydrogenase (Decarboxylating); Hyperglycinemia, Nonketot

2020
Seventeen-year long-term survival of a case of neonatal nonketotic hyperglycinemia.
    Pediatrics international : official journal of the Japan Pediatric Society, 2020, Volume: 62, Issue:9

    Topics: Adolescent; Amino Acid Metabolism, Inborn Errors; Glycine; Humans; Hyperglycinemia, Nonketotic; Infa

2020
Nonketotic Hyperglycinemia in Tunisia. Report upon a Series of 69 Patients.
    Neuropediatrics, 2020, Volume: 51, Issue:5

    Topics: Age of Onset; Child, Preschool; Consanguinity; Female; Glycine; Humans; Hyperglycinemia, Nonketotic;

2020
GLYT1 encephalopathy: Further delineation of disease phenotype and discussion of pathophysiological mechanisms.
    American journal of medical genetics. Part A, 2021, Volume: 185, Issue:2

    Topics: Abortion, Spontaneous; Arthrogryposis; Female; Genetic Predisposition to Disease; Glycine; Glycine P

2021
Genomic analyses of glycine decarboxylase neurogenic mutations yield a large-scale prediction model for prenatal disease.
    PLoS genetics, 2021, Volume: 17, Issue:2

    Topics: Animals; Disease Models, Animal; Female; Genomics; Genotype; Glycine; Glycine Dehydrogenase (Decarbo

2021
Elevated preoptic brain activity in zebrafish glial glycine transporter mutants is linked to lethargy-like behaviors and delayed emergence from anesthesia.
    Scientific reports, 2021, 02-04, Volume: 11, Issue:1

    Topics: Aminobenzoates; Anesthesia, General; Anesthetics; Animals; Animals, Genetically Modified; Craniotomy

2021
Genotypic and phenotypic features in Turkish patients with classic nonketotic hyperglycinemia.
    Metabolic brain disease, 2021, Volume: 36, Issue:6

    Topics: Agenesis of Corpus Callosum; Amino Acid Oxidoreductases; Female; Genotype; Glycine; Humans; Hypergly

2021
Biallelic start loss variant, c.1A > G in GCSH is associated with variant nonketotic hyperglycinemia.
    Clinical genetics, 2021, Volume: 100, Issue:2

    Topics: Child, Preschool; Female; Glycine; Glycine Decarboxylase Complex H-Protein; Humans; Hyperglycinemia,

2021
X-Linked Cobalamin Disorder (HCFC1) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic Acid.
    Pediatric neurology, 2017, Volume: 71

    Topics: Biomarkers; Brain; Diagnosis, Differential; Genetic Diseases, X-Linked; Glycine; Humans; Hyperglycin

2017
d-Glyceric aciduria does not cause nonketotic hyperglycinemia: A historic co-occurrence.
    Molecular genetics and metabolism, 2017, Volume: 121, Issue:2

    Topics: Amino Acid Oxidoreductases; Aminomethyltransferase; Carrier Proteins; Diagnosis, Differential; Epile

2017
A novel compound heterozygous variant identified in GLDC gene in a Chinese family with non-ketotic hyperglycinemia.
    BMC medical genetics, 2018, 01-05, Volume: 19, Issue:1

    Topics: Amino Acid Sequence; Asian People; China; Exons; Female; Genetic Variation; Genotype; Glycine; Glyci

2018
Why does hyperglycinemia exhibit so grave brain anomalies and so severe neurological symptoms?
    Journal of theoretical biology, 2018, 10-14, Volume: 455

    Topics: Brain; Cell Proliferation; DNA; Glycine; Humans; Hyperglycinemia, Nonketotic; Models, Neurological;

2018
Glycine decarboxylase deficiency-induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level.
    JCI insight, 2018, 11-02, Volume: 3, Issue:21

    Topics: Animals; Brain; CRISPR-Associated Protein 9; Dextromethorphan; Excitatory Amino Acid Antagonists; Fa

2018
The effect of hyperglycinemic treatment in captive-bred Vervet monkeys (Chlorocebus aethiops).
    Metabolic brain disease, 2019, Volume: 34, Issue:5

    Topics: Animals; Chlorocebus aethiops; Dextromethorphan; Glycine; Hyperglycinemia, Nonketotic; Sodium Benzoa

2019
Diagnosis of glycine encephalopathy in a pediatric patient by detection of a GLDC mutation during initial next generation DNA sequencing.
    Metabolic brain disease, 2014, Volume: 29, Issue:1

    Topics: Base Sequence; DNA Mutational Analysis; Female; Genes, Recessive; Glycine; Glycine Dehydrogenase (De

2014
Two novel missense mutations in nonketotic hyperglycinemia.
    Journal of child neurology, 2015, Volume: 30, Issue:6

    Topics: Aminomethyltransferase; Epilepsies, Myoclonic; Female; Genetic Predisposition to Disease; Glycine; G

2015
Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice.
    Nature communications, 2015, Mar-04, Volume: 6

    Topics: Animals; Base Sequence; DNA Primers; Folic Acid; Formates; Galactosides; Gas Chromatography-Mass Spe

2015
Novel compound heterozygous LIAS mutations cause glycine encephalopathy.
    Journal of human genetics, 2015, Volume: 60, Issue:10

    Topics: Adult; Exome; Female; Glycine; Heterozygote; Humans; Hyperglycinemia, Nonketotic; Mutation

2015
Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia.
    Annals of neurology, 2015, Volume: 78, Issue:4

    Topics: Animals; Chlorocebus aethiops; COS Cells; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Infa

2015
The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT.
    Genetics in medicine : official journal of the American College of Medical Genetics, 2017, Volume: 19, Issue:1

    Topics: Alleles; Aminomethyltransferase; Dihydrolipoamide Dehydrogenase; Exons; Female; Genetic Testing; Gen

2017
Biochemical diagnosis of nonketotic hyperglycinemia in Cuba.
    Neurologia, 2018, Volume: 33, Issue:8

    Topics: Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant; Infant, Newborn; Male

2018
Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans.
    Human genetics, 2016, Volume: 135, Issue:11

    Topics: Amino Acid Oxidoreductases; Animals; Base Sequence; Carrier Proteins; Exome; Female; Glycine; Glycin

2016
Loss of Glycine Transporter 1 Causes a Subtype of Glycine Encephalopathy with Arthrogryposis and Mildly Elevated Cerebrospinal Fluid Glycine.
    American journal of human genetics, 2016, Nov-03, Volume: 99, Issue:5

    Topics: Animals; Arthrogryposis; Child, Preschool; Female; Gene Deletion; Gene Expression Regulation; Glycin

2016
Glycine Administration Alters MAPK Signaling Pathways and Causes Neuronal Damage in Rat Brain: Putative Mechanisms Involved in the Neurological Dysfunction in Nonketotic Hyperglycinemia.
    Molecular neurobiology, 2018, Volume: 55, Issue:1

    Topics: Animals; Brain; Corpus Striatum; Dizocilpine Maleate; Glial Fibrillary Acidic Protein; Glycine; Hype

2018
Nonketotic hyperglycinemia: Functional assessment of missense variants in GLDC to understand phenotypes of the disease.
    Human mutation, 2017, Volume: 38, Issue:6

    Topics: Exons; Gene Expression Regulation, Enzymologic; Glycine; Glycine Dehydrogenase (Decarboxylating); Hu

2017
Glycine provokes lipid oxidative damage and reduces the antioxidant defenses in brain cortex of young rats.
    Cellular and molecular neurobiology, 2009, Volume: 29, Issue:2

    Topics: Animals; Antioxidants; Cerebral Cortex; Cytoprotection; Dose-Response Relationship, Drug; Glutathion

2009
Intracerebral blood and MRS in neonatal nonketotic hyperglycinemia.
    Pediatric neurology, 2010, Volume: 42, Issue:3

    Topics: Brain; Cerebral Hemorrhage; Female; Glycine; Hiccup; Humans; Hyperglycinemia, Nonketotic; Infant, Ne

2010
A floppy neonate with respiratory failure and burst suppression EEG (case presentation).
    Acta paediatrica (Oslo, Norway : 1992), 2010, Volume: 99, Issue:3

    Topics: Diagnosis, Differential; Electroencephalography; Female; Glycine; Humans; Hyperglycinemia, Nonketoti

2010
Nonketotic hyperglycinemia: proposal of a diagnostic and treatment strategy.
    Pediatric neurology, 2010, Volume: 43, Issue:3

    Topics: Glycine; Humans; Hyperglycinemia, Nonketotic; Infant, Newborn; Male

2010
Nitrous oxide for glycine encephalopathy.
    Paediatric anaesthesia, 2010, Volume: 20, Issue:10

    Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Electroencephalography; Gastrostomy; Glycine; Human

2010
Pitfalls in measuring cerebrospinal fluid glycine levels in infants with encephalopathy.
    Journal of child neurology, 2011, Volume: 26, Issue:6

    Topics: Child, Preschool; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Hypoxia, Brain; Infant; Magn

2011
Late-onset nonketotic hyperglycinemia caused by a novel homozygous missense mutation in the GLDC gene.
    Molecular genetics and metabolism, 2011, Volume: 103, Issue:2

    Topics: Base Sequence; Child; Dextromethorphan; Excitatory Amino Acid Antagonists; Glycine; Glycine Dehydrog

2011
Glycine intrastriatal administration induces lipid and protein oxidative damage and alters the enzymatic antioxidant defenses in rat brain.
    Life sciences, 2011, Aug-15, Volume: 89, Issue:7-8

    Topics: Animals; Brain; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Glycine; Glycine Agent

2011
Paracetamol prevents hyperglycinemia in vervet monkeys treated with valproate.
    Metabolic brain disease, 2012, Volume: 27, Issue:3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anticonvulsants; Chlorocebus aethiops; Disease Mod

2012
Nonketotic hyperglycinemia: a cause of encephalopathy in children.
    Journal of child neurology, 2013, Volume: 28, Issue:2

    Topics: Child; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Intellectual Disability; Lennox Gastaut

2013
Magnetic resonance spectroscopy study of glycine pathways in nonketotic hyperglycinemia.
    Pediatric research, 2002, Volume: 52, Issue:2

    Topics: Aspartic Acid; Brain; Child, Preschool; Dextromethorphan; Excitatory Amino Acid Antagonists; Female;

2002
Pitfalls in the diagnosis of glycine encephalopathy (non-ketotic hyperglycinemia).
    Developmental medicine and child neurology, 2002, Volume: 44, Issue:10

    Topics: Anticonvulsants; Brain Diseases, Metabolic, Inborn; Child, Preschool; Chromosome Aberrations; Consan

2002
Prenatal diagnosis of hypoplasia of the corpus callosum in association with non-ketotic hyperglycinemia.
    Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2002, Volume: 20, Issue:6

    Topics: Abnormalities, Multiple; Agenesis of Corpus Callosum; Amino Acid Metabolism, Inborn Errors; Electroe

2002
Molecular genetic and potential biochemical characteristics of patients with T-protein deficiency as a cause of glycine encephalopathy (NKH).
    Molecular genetics and metabolism, 2003, Volume: 79, Issue:4

    Topics: Aminomethyltransferase; Base Sequence; Glycine; Herpesvirus 4, Human; Humans; Hydroxymethyl and Form

2003
Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.
    Journal of child neurology, 2004, Volume: 19, Issue:1

    Topics: Brain; Child, Preschool; Chromosome Aberrations; Dextromethorphan; Diazepam; Disease Progression; Di

2004
Persistent NKH with transient or absent symptoms and a homozygous GLDC mutation.
    Annals of neurology, 2004, Volume: 56, Issue:1

    Topics: Adult; Amino Acid Oxidoreductases; Child, Preschool; DNA Mutational Analysis; Excitatory Amino Acid

2004
Natural history of nonketotic hyperglycinemia in 65 patients.
    Neurology, 2004, Nov-23, Volume: 63, Issue:10

    Topics: Adolescent; Age of Onset; Agenesis of Corpus Callosum; Anticonvulsants; Apnea; Child; Child, Prescho

2004
Four cases of neonatal non-ketotic hyperglycinaemia.
    Annals of tropical paediatrics, 2004, Volume: 24, Issue:4

    Topics: Biomarkers; Fatal Outcome; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant, Newborn; Male

2004
Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation.
    Neurology, 2005, Apr-26, Volume: 64, Issue:8

    Topics: Adolescent; Alternative Splicing; Arabs; Brain; Brain Chemistry; Child; Child, Preschool; Disease Pr

2005
A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem.
    Journal of human genetics, 2005, Volume: 50, Issue:5

    Topics: Amino Acid Oxidoreductases; Amino Acid Substitution; Arabs; Codon, Initiator; Female; Glycine; Glyci

2005
Crystal structure of human T-protein of glycine cleavage system at 2.0 A resolution and its implication for understanding non-ketotic hyperglycinemia.
    Journal of molecular biology, 2005, Sep-02, Volume: 351, Issue:5

    Topics: Amino Acid Sequence; Aminomethyltransferase; Animals; Arginine; Asparagine; Binding Sites; Catalytic

2005
Non-ketotic hyperglycinemia as the cause of infant seizures--the case study.
    Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina, 2004, Volume: 59, Issue:1

    Topics: Brain; Diagnosis, Differential; Electroencephalography; Female; Follow-Up Studies; Glycine; Humans;

2004
Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.
    Journal of inherited metabolic disease, 2005, Volume: 28, Issue:5

    Topics: Adolescent; Age Factors; Age of Onset; Amino Acid Oxidoreductases; Anti-Infective Agents; Benzoates;

2005
Glycine encephalopathy (nonketotic hyperglycinemia): comments and speculations.
    American journal of medical genetics. Part A, 2006, Jan-15, Volume: 140, Issue:2

    Topics: Aminomethyltransferase; Glycine; Glycine Dehydrogenase (Decarboxylating); Humans; Hyperglycinemia, N

2006
Genetic heterogeneity of the GLDC gene in 28 unrelated patients with glycine encephalopathy.
    Journal of inherited metabolic disease, 2006, Volume: 29, Issue:1

    Topics: Alleles; Chromatography, High Pressure Liquid; DNA Mutational Analysis; DNA Primers; Female; Gene De

2006
Glycine encephalopathy and delayed emergence from anesthesia.
    Anesthesia and analgesia, 2006, Volume: 103, Issue:6

    Topics: Anesthesia; Child, Preschool; Female; Glycine; Humans; Hyperglycinemia, Nonketotic

2006
Non-ketotic hyperglycinemia is usually not detectable by tandem mass spectrometry newborn screening.
    Molecular genetics and metabolism, 2007, Volume: 90, Issue:4

    Topics: Glycine; Humans; Hyperglycinemia, Nonketotic; Infant; Infant, Newborn; Neonatal Screening; Tandem Ma

2007
Late-onset nonketotic hyperglycinemia with leukodystrophy and an unusual clinical course.
    Pediatric neurology, 2007, Volume: 37, Issue:4

    Topics: Age of Onset; Brain Diseases, Metabolic; Cerebral Palsy; Child, Preschool; Female; Gait; Glycine; Hu

2007
Neonatal nonketotic hyperglycinemia.
    Indian journal of pediatrics, 2007, Volume: 74, Issue:12

    Topics: Amino Acid Metabolism, Inborn Errors; Disease Progression; Fatal Outcome; Glycine; Humans; Hyperglyc

2007
Practical difficulties in the diagnosis of transient non-ketotic hyperglycinaemia.
    Developmental medicine and child neurology, 2008, Volume: 50, Issue:2

    Topics: Amino Acids; Diagnosis, Differential; Female; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant,

2008
Prenatal diagnosis of non-ketotic hyperglycinaemia: enzymatic diagnosis in 28 families and DNA diagnosis detecting prevalent Finnish and Israeli-Arab mutations.
    Prenatal diagnosis, 1999, Volume: 19, Issue:8

    Topics: Amino Acid Oxidoreductases; Arabs; Carrier Proteins; Case-Control Studies; Chorionic Villi Sampling;

1999
Atypical nonketotic hyperglycinemia with normal cerebrospinal fluid to plasma glycine ratio.
    Journal of child neurology, 1999, Volume: 14, Issue:7

    Topics: Adolescent; Child; Epilepsy, Complex Partial; Female; Glycine; Humans; Hyperglycinemia, Nonketotic;

1999
Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter.
    Journal of child neurology, 1999, Volume: 14, Issue:11

    Topics: Adolescent; Adult; Biomarkers; Brain; Brain Diseases; Child; Child, Preschool; Excitatory Amino Acid

1999
Transient nonketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures.
    Pediatric neurology, 2000, Volume: 22, Issue:3

    Topics: Asphyxia Neonatorum; Brain; Electroencephalography; Glycine; Humans; Hyperglycinemia, Nonketotic; In

2000
Biochemical and molecular investigations of patients with nonketotic hyperglycinemia.
    Molecular genetics and metabolism, 2000, Volume: 70, Issue:2

    Topics: Amino Acid Sequence; DNA Mutational Analysis; DNA Primers; Exons; Female; Glycine; Homocysteine S-Me

2000
Recurrent mutations in P- and T-proteins of the glycine cleavage complex and a novel T-protein mutation (N145I): a strategy for the molecular investigation of patients with nonketotic hyperglycinemia (NKH).
    Molecular genetics and metabolism, 2001, Volume: 72, Issue:4

    Topics: Amino Acid Oxidoreductases; Aminomethyltransferase; DNA Primers; Exons; Gene Frequency; Glycine; Gly

2001
In vivo 1H magnetic resonance spectroscopic measurement of brain glycine levels in nonketotic hyperglycinemia.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2001, Volume: 11, Issue:2

    Topics: Aspartic Acid; Brain; Brain Diseases, Metabolic; Choline; Chromosome Aberrations; Chromosome Disorde

2001
Chromosomal localization, structure, single-nucleotide polymorphisms, and expression of the human H-protein gene of the glycine cleavage system (GCSH), a candidate gene for nonketotic hyperglycinemia.
    Journal of human genetics, 2001, Volume: 46, Issue:7

    Topics: Alleles; Amino Acid Oxidoreductases; Base Sequence; Chromosome Mapping; Chromosomes, Human, Pair 16;

2001
Structure and expression of the glycine cleavage system in rat central nervous system.
    Brain research. Molecular brain research, 2001, Oct-19, Volume: 94, Issue:1-2

    Topics: Age Factors; Amino Acid Oxidoreductases; Amino Acid Sequence; Animals; Astrocytes; Base Sequence; Br

2001
Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: in vivo-in vitro (ex vivo) correlation.
    European radiology, 2002, Volume: 12, Issue:4

    Topics: Brain; Brain Chemistry; Glycine; Humans; Hyperglycinemia, Nonketotic; Infant, Newborn; Magnetic Reso

2002